ICD-10 Coding for Symptomatic Ascites in Carcinomatosis(C48.2, C48.2U, C78.6)
Learn about ICD-10 coding for symptomatic ascites in the setting of carcinomatosis, including code relationships, documentation requirements, and common pitfalls.
Complete code families applicable to Symptomatic Ascites in Carcinomatosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C78.6 | Secondary malignant neoplasm of retroperitoneum and peritoneum | Use when ascites is secondary to peritoneal carcinomatosis. |
|
| R18.0 | Malignant ascites | Use when ascites is confirmed to be malignant. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSymptomatic Ascites in Carcinomatosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Symptomatic Ascites in Carcinomatosis.
Documenting ascites without specifying cause
Impact
Clinical: Leads to incomplete clinical picture., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Always specify the underlying cause of ascites.
Coding R18.0 without a primary malignancy code
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Always pair R18.0 with the appropriate primary malignancy code.
Code Sequencing
Impact
Incorrect sequencing of malignancy and ascites codes.
Mitigation
Ensure primary malignancy is coded first.